PBH
Price
$80.77
Change
-$0.38 (-0.47%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
3.6B
34 days until earnings call
QNTM
Price
$21.61
Change
+$0.49 (+2.32%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
60.68M
Interact to see
Advertisement

PBH vs QNTM

Header iconPBH vs QNTM Comparison
Open Charts PBH vs QNTMBanner chart's image
Prestige Consumer Healthcare
Price$80.77
Change-$0.38 (-0.47%)
Volume$5.04K
Capitalization3.6B
Quantum Biopharma
Price$21.61
Change+$0.49 (+2.32%)
Volume$1.39K
Capitalization60.68M
PBH vs QNTM Comparison Chart in %
Loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBH vs. QNTM commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a StrongBuy and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (PBH: $81.15 vs. QNTM: $21.12)
Brand notoriety: PBH and QNTM are both not notable
PBH represents the Pharmaceuticals: Other, while QNTM is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBH: 169% vs. QNTM: 149%
Market capitalization -- PBH: $3.6B vs. QNTM: $60.68M
PBH [@Pharmaceuticals: Other] is valued at $3.6B. QNTM’s [@Biotechnology] market capitalization is $60.68M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 1 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • PBH’s FA Score: 1 green, 4 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, PBH is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 3 TA indicator(s) are bullish while QNTM’s TA Score has 2 bullish TA indicator(s).

  • PBH’s TA Score: 3 bullish, 6 bearish.
  • QNTM’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, PBH is a better buy in the short-term than QNTM.

Price Growth

PBH (@Pharmaceuticals: Other) experienced а -2.98% price change this week, while QNTM (@Biotechnology) price change was -30.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +113.87%. For the same industry, the average monthly price growth was +74.83%, and the average quarterly price growth was +80.55%.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

PBH is expected to report earnings on Jul 31, 2025.

QNTM is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+113.87% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.6B) has a higher market cap than QNTM($60.7M). QNTM YTD gains are higher at: 473.913 vs. PBH (3.919). PBH has higher annual earnings (EBITDA): 10.8M vs. QNTM (-20.68M). PBH has more cash in the bank: 63.6M vs. QNTM (3.54M). QNTM has less debt than PBH: QNTM (1.28M) vs PBH (1.21B). PBH has higher revenues than QNTM: PBH (1.13B) vs QNTM (0).
PBHQNTMPBH / QNTM
Capitalization3.6B60.7M5,936%
EBITDA10.8M-20.68M-52%
Gain YTD3.919473.9131%
P/E Ratio14.90N/A-
Revenue1.13B0-
Total Cash63.6M3.54M1,797%
Total Debt1.21B1.28M94,844%
FUNDAMENTALS RATINGS
PBH vs QNTM: Fundamental Ratings
PBH
QNTM
OUTLOOK RATING
1..100
5723
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
60100
PRICE GROWTH RATING
1..100
5734
P/E GROWTH RATING
1..100
36100
SEASONALITY SCORE
1..100
24n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNTM's Valuation (72) in the null industry is in the same range as PBH (82) in the Pharmaceuticals Other industry. This means that QNTM’s stock grew similarly to PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for QNTM (100) in the null industry. This means that PBH’s stock grew significantly faster than QNTM’s over the last 12 months.

PBH's SMR Rating (60) in the Pharmaceuticals Other industry is somewhat better than the same rating for QNTM (100) in the null industry. This means that PBH’s stock grew somewhat faster than QNTM’s over the last 12 months.

QNTM's Price Growth Rating (34) in the null industry is in the same range as PBH (57) in the Pharmaceuticals Other industry. This means that QNTM’s stock grew similarly to PBH’s over the last 12 months.

PBH's P/E Growth Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for QNTM (100) in the null industry. This means that PBH’s stock grew somewhat faster than QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHQNTM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
38%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
38%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JPXN79.101.57
+2.03%
iShares JPX-Nikkei 400 ETF
ETJ8.910.07
+0.79%
Eaton Vance Risk - Managed Diversified Equity Income Fund
DEHP27.910.18
+0.64%
Dimensional Em Mkts High Prof ETF
BSCS20.470.04
+0.20%
Invesco BulletShares 2028 Corp Bd ETF
CAFX24.970.05
+0.18%
Congress Intermediate Bond ETF

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.72%
PAHC - PBH
51%
Loosely correlated
+1.49%
VTRS - PBH
41%
Loosely correlated
+2.59%
ZTS - PBH
35%
Loosely correlated
-0.92%
AMRX - PBH
35%
Loosely correlated
+0.99%
IRWD - PBH
32%
Poorly correlated
+3.90%
More

QNTM and

Correlation & Price change

A.I.dvisor tells us that QNTM and CPIX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNTM and CPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
-13.34%
CPIX - QNTM
26%
Poorly correlated
+5.10%
EBS - QNTM
24%
Poorly correlated
+0.89%
RNA - QNTM
24%
Poorly correlated
-0.23%
PBH - QNTM
24%
Poorly correlated
-0.72%
ATAI - QNTM
23%
Poorly correlated
+2.27%
More